Results 111 to 120 of about 789,461 (263)

Evaluation of pelvic lymph nodes in patients with prostate cancer: the role of Diffusion Weighted MR Imaging (DW-MRI) [PDF]

, 2012
PURPOSE: To evaluate the role of MRI Diffusion-Weighted Imaging (DWI) to detect pelvic lymph node metastases in patients with prostate cancer (PC) candidate to radical prostatectomy and extended pelvic lymph node dissection.
VALLINI, VALENTINA
core  

Evaluation of triplet therapy combined with robot‐assisted cytoreductive prostatectomy for high‐volume metastatic prostate cancer: a multicentre randomised controlled trial protocol

BJU International, EarlyView.
Background Prostate cancer (PCa) is the second most common cancer in men. For patients with high‐volume metastatic PCa (mPCa) who are fit for docetaxel, a triplet therapy regimen consisting of androgen deprivation therapy (ADT), chemotherapy, and an androgen receptor pathway inhibitor (ARPI) is recommended.
Xiangwei Yang, Zhuobin He, Jian Chen, Hanqi Lei, Binyuan Yan, Linze Chen, Hong Liu, Jun Pang   +7 more
wiley   +1 more source

Comparison of efficacy between robot-assisted laparoscopic and conventional laparoscopic radical prostatectomy and analysis on influencing factors

陆军军医大学学报
Objective To compare the therapeutic efficacy of robot-assisted laparoscopic radical prostatectomy versus conventional laparoscopic radical prostatectomy, and analyze the factors influencing treatment outcomes.
CHEN Qiming, CHEN Jian, LIU Qiuli
doaj   +1 more source

Sexual function after prostate cancer surgery or radiotherapy in an international registry

BJU International, EarlyView.
Objectives Our objective was to evaluate patient‐reported sexual function (SF) outcomes and sexual aid use 12 months after curative treatment for prostate cancer (PC). Patients & Methods This prospective registry‐based cohort study analysed men with localized or locally advanced PC enrolled in the TrueNTH Global Registry.
Y. Hess‐Busch, C. Darr, L. Püllen, M. Al‐Nader, M. Wahl, A. V. Bailey, H. Wilhalme, J. Lee, B. Hadaschik, J. Hess, on behalf of the TrueNTH Global Registry   +10 more
wiley   +1 more source

Technical Modifications Employed in RARP to Improve Early Continence Recovery: A Literature Review

Life
Prostate cancer presents a substantial challenge, necessitating a delicate balance between effective treatment and preserving the overall quality of life for men, while robot-assisted radical prostatectomy (RARP) stands as the premier surgical approach ...
Ernesto Di Mauro, Roberto La Rocca, Francesco Di Bello, Ugo Amicuzi, Pasquale Reccia, Luigi De Luca, Francesco Paolo Calace, Michelangelo Olivetta, Gennaro Mattiello, Pietro Saldutto, Pierluigi Russo, Lorenzo Romano, Lorenzo Spirito, Carmine Sciorio, Biagio Barone, Felice Crocetto, Francesco Mastrangelo, Giuseppe Celentano, Antonio Tufano, Luigi Napolitano, Vincenzo Maria Altieri   +20 more
doaj   +1 more source

Predictors of Long-Term Urinary Incontinence After Robot–Assisted Laparoscopic Prostatectomy

Research and Reports in Urology, 2023
Kaori Yamashita, Yu Kijima, Eri Sekido, Naoki Nagasaka, Masashi Inui Department of Urology, Tokyo Women’s Medical University Yachiyo Medical Center, Yachiyo-city, JapanCorrespondence: Kaori Yamashita, Department of Urology, Tokyo Women’s Medical ...
Yamashita K, Kijima Y, Sekido E, Nagasaka N, Inui M   +4 more
doaj  

Perioperative propranolol during robotic-assisted radical prostatectomy: A randomised, double-blind, placebo-controlled, pilot trial (PeP-RALP). [PDF]

BJUI Compass
Abstract Objective This study aimed to determine the feasibility and safety of administering perioperative propranolol, as an adjunct to reduce prostate cancer recurrence, in patients undergoing robotic‐assisted laparoscopic prostatectomy (RALP) for European Association of Urology (EAU) intermediate‐ or high‐risk prostate cancer.
Sivanesan S, Ramberg H, Kristiansen T, Thapa SB, Bjøre M, Berge V, Ottosson F, Brennhovd B, Storås AMH, Thorsby PM, Dahl SR, Urbanucci A, Grytli HH, Bjerke L, Taskén KA.   +14 more
europepmc   +2 more sources

The PART randomised trial protocol: Partial Ablation versus Radical Treatment for prostate cancer

BJU International, EarlyView.
Objectives Primary objective: to determine whether prostate gland partial ablation (PA) has non‐inferior oncological treatment success vs radical treatment (RT) of localised intermediate‐risk prostate cancer (irPCa). Secondary objectives: to compare (i) participant‐reported urinary and sexual dysfunction side effects, (ii) short/medium term serious ...
Richard J. Bryant, Tom Leslie, Marc Laniado, Abhishek Sharma, Alistair Grey, John Withington, Christopher Blick, Edward Streeter, Sanjeev Kotwal, Oliver Hulson, William Cross, Daniel W. Good, Altan Omer, Taimur T. Shah, Nishant Bedi, Luke Stroman, Caroline Moore, Prasanna Sooriakumaran, Hashim U. Ahmed, Simon F. Brewster, Vicki S. Barber, Aimi Hewitt, Clare Calvert, Jessica Scaife, Derek Shepherd, Filipa Landeiro, Jane Wolstenholme, Philip Camilleri, Clare Verrill, Shelagh Lovell, Martin Pirkl, Fergus Gleeson, Roxanne Williams, Jo Cook, Catherine R. Holt, Martyn Hill, Jonathan Cook, James Radford, Ioana R. Marian, Ruth Macpherson, Daisy Elliott, Jenny L. Donovan, Freddie C. Hamdy   +42 more
wiley   +1 more source

Radical Prostatectomy is a Valuable Treatment Alternative in Patients with High-Risk Prostate Cancer

, 2015
Objective To review the high-risk prostate cancer (PCa) patient database with special emphasis on the role of radical prostatectomy (RP) in comparison to external beam radiotherapy (EBRT).
Turkeri, Levent, Naşide Mangır, Yılören Tanıdır, Mangir, NAŞİDE, Tuncay Top, TİNAY, İLKER, İlker Tinay, TANIDIR, YILÖREN, Top, Tuncay, Levent Türkeri   +9 more
core   +1 more source

A Von Willebrand Faktor multimer- és konformáció függő aktivitása és a vascularis haematologia = The structure and conformation dependent activity of VWF and its implications on vascular haematology [PDF]

, 2010
A von Willebrand faktor (VWF) egy nagy molekulatömegű azonos alegységekből felépülő glikoprotein, mely alegységenként kollagén és thrombocyták számára szolgáló kötőhellyel is rendelkezik.
Hársfalvi, Jolán, Fazakas, Ferenc, Budainé Dr. Tóth, Judit, Udvardy, Miklós László, Szántó, Tímea, Nagy, Béla, Elek, Norbert, Kellermayer, Miklós Sándor Zoltán, Schlammadinger, Ágota, Szabó, István, Mendelboum, Shlomit, Tornai, István   +11 more
core   +1 more source